v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities      
Net increase (decrease) in net assets resulting from operations $ 94,385 $ 68,960 $ 16,109
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Amortization of deferred debt issuance costs 4,061 1,644 327
Amortization of deferred offering costs 68 134 83
Accretion of discounts and amortization of premiums (5,420) (3,078) (641)
Net realized (gain) loss on investments 0 (30) (16)
Net realized (gain) loss on foreign currency transactions (263) (155) 46
Net change in unrealized (appreciation) depreciation on investments (5,293) (14,348) (2,595)
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (430) 20 (137)
Net change in unrealized (appreciation) depreciation on forward currency contracts 864 0 0
Proceeds from (fundings of) revolving loans, net (5,121) (2,253) (269)
Fundings of investments (1,004,018) (999,116) (205,451)
Proceeds from principal payments and sales of portfolio investments 139,651 36,279 4,424
Payment-in-kind interest capitalized (9,486) (6,286) (1,629)
Non-cash dividends capitalized (628) (181) (114)
Proceeds from non-cash dividends 208 0 0
Changes in operating assets and liabilities:      
Interest receivable (3,079) (13,464) (2,556)
Receivable for investments 3,730 (4,171) (914)
Other assets (723) (85) (24)
Interest payable 5,951 9,751 2,057
Management and income incentive fees payable 2,099 3,319 217
Accrued trustee fees 5 22 (15)
Accounts payable and other liabilities 1,010 1,368 31
Net cash provided by (used in) operating activities (782,429) (921,670) (191,067)
Cash flows from financing activities      
Borrowings on debt 2,340,403 999,356 160,342
Repayments of debt (1,849,470) (487,400) (48,392)
Proceeds from other short-term borrowings 0 481,469 0
Repayments on other short-term borrowings 0 (481,469) 0
Capitalized debt issuance costs (4,471) (8,511) (808)
Deferred offering costs 0 (49) (53)
Proceeds from issuance of common shares 400,311 456,761 109,983
Distributions paid (72,147) (46,642) (9,009)
Net cash provided by (used in) financing activities 814,626 913,515 212,063
Net change in cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies 32,197 (8,155) 20,996
Effect of foreign currency exchange rates (737) 163 97
Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, beginning of period 34,847 [1] 42,839 21,746
Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, end of period 66,307 [1] 34,847 [1] 42,839
Supplemental disclosure of cash flow information:      
Cash paid during the period for interest 54,654 26,791 4,842
Distributions declared for the period 94,385 68,960 16,109
Supplemental disclosure of non-cash operating and financing activity:      
Change in capital call receivable 94 (40) 28
Stock issued in connection with dividend reinvestment plan 17,949 10,797 3,247
Change in distributions payable $ 4,289 $ 11,521 $ 3,853
[1] See Note 2 for a description of cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies.